These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus. Chowdhury S; Wang S; Dunai J; Kilpatrick R; Oestricker LZ; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM PLoS One; 2016; 11(6):e0156852. PubMed ID: 27304975 [TBL] [Abstract][Full Text] [Related]
4. The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus. Chowdhury S; Wang S; Patterson BW; Reeds DN; Wice BM Regul Pept; 2013 Nov; 187():42-50. PubMed ID: 24183983 [TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471 [TBL] [Abstract][Full Text] [Related]
7. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss. Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898 [TBL] [Abstract][Full Text] [Related]
8. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus. Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029 [TBL] [Abstract][Full Text] [Related]
9. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622 [TBL] [Abstract][Full Text] [Related]
10. Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044 [TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. Christensen MB Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187 [TBL] [Abstract][Full Text] [Related]
12. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
13. Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes. Chia CW; Carlson OD; Kim W; Shin YK; Charles CP; Kim HS; Melvin DL; Egan JM Diabetes; 2009 Jun; 58(6):1342-9. PubMed ID: 19276444 [TBL] [Abstract][Full Text] [Related]
14. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets. Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701 [TBL] [Abstract][Full Text] [Related]
15. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041 [TBL] [Abstract][Full Text] [Related]
16. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284 [TBL] [Abstract][Full Text] [Related]
17. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405 [TBL] [Abstract][Full Text] [Related]
18. Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells. Timper K; Dalmas E; Dror E; Rütti S; Thienel C; Sauter NS; Bouzakri K; Bédat B; Pattou F; Kerr-Conte J; Böni-Schnetzler M; Donath MY Gastroenterology; 2016 Jul; 151(1):165-79. PubMed ID: 26971825 [TBL] [Abstract][Full Text] [Related]
19. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice. Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392 [TBL] [Abstract][Full Text] [Related]